We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
AUM
$238M
AUM Growth
+$968K
Cap. Flow
+$11M
Cap. Flow %
4.61%
Top 10 Hldgs %
58.37%
Holding
128
New
17
Increased
22
Reduced
18
Closed
9

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.02M
2
LOW icon
Lowe's Companies
LOW
+$4.54M
3
HHH icon
Howard Hughes
HHH
+$1.61M
4
INDP icon
Indaptus Therapeutics
INDP
+$1.13M
5
APC
Anadarko Petroleum
APC
+$1.13M

Sector Composition

Rank Sector Weight
1 Healthcare 29.41%
2 Industrials 14.74%
3 Financials 11.25%
4 Communication Services 8.3%
5 Consumer Discretionary 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZNP
26
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.75M 0.74%
64,364
+14,318
+29% +$370K
XENE icon
27
Xenon Pharmaceuticals
XENE
$5.81B
$1.69M 0.71%
187,311
+7,921
+4% +$74.9K
CELG
28
DELISTED
Celgene Corp
CELG
$1.57M 0.66%
15,847
BLU
29
DELISTED
BELLUS Health Inc.
BLU
$1.56M 0.66%
+242,611
New +$1.71M
BMY icon
30
Bristol-Myers Squibb
BMY
$136B
$1.51M 0.64%
29,868
+2,788
+10% +$131K
VKTX icon
31
Viking Therapeutics
VKTX
$3.75B
$1.5M 0.63%
218,102
AB icon
32
AllianceBernstein
AB
$3.43B
$1.48M 0.62%
50,500
MIK
33
DELISTED
Michaels Stores, Inc
MIK
$1.47M 0.62%
150,000
-150,000
-50% -$1.12M
CHRS icon
34
Coherus Oncology
CHRS
$218M
$1.28M 0.54%
63,387
+1,000
+2% +$20K
AIMT
35
DELISTED
Aimmune Therapeutics
AIMT
$1.17M 0.49%
55,990
-1,466
-3% -$29.9K
FOMX
36
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.13M 0.47%
371,146
+100
+0% +$281
STML
37
DELISTED
Stemline Therapeutics, Inc.
STML
$1.12M 0.47%
107,934
+7,300
+7% +$95.5K
VZ icon
38
Verizon
VZ
$208B
$1.11M 0.46%
18,311
RHP icon
39
Ryman Hospitality Properties
RHP
$8.92B
$1.01M 0.43%
12,400
FNM.PRM
40
DELISTED
FEDERAL NATIONAL MORTGAGE ASSOC PFD SER M
FNM.PRM
$978K 0.41%
+43,000
New +$978K
JNJ icon
41
Johnson & Johnson
JNJ
$646B
$942K 0.4%
7,280
XRN.PRA
42
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
$78.1M
$930K 0.39%
35,000
DD icon
43
DuPont de Nemours
DD
$18.5B
$895K 0.38%
9,994
MDLZ icon
44
Mondelez International
MDLZ
$79.6B
$879K 0.37%
15,900
XLRN
45
DELISTED
Acceleron Pharma
XLRN
$859K 0.36%
21,749
+3,949
+22% +$171K
CNQ icon
46
Canadian Natural Resources
CNQ
$101B
$853K 0.36%
65,415
-644
-1% -$7.98K
KMB icon
47
Kimberly-Clark
KMB
$36.4B
$852K 0.36%
6,000
T icon
48
AT&T
T
$178B
$835K 0.35%
29,194
CPRX
49
DELISTED
Catalyst Pharmaceutical
CPRX
$804K 0.34%
151,415
-191,932
-56% -$1.02M
FNM.PRS
50
DELISTED
FEDERAL NATIONAL MORTGAGE ASSOCIATION PFD SER S (USA)
FNM.PRS
$801K 0.34%
+60,000
New +$801K

Similar funds

David M. Knott's Q3 2019 Portfolio in Review

As of Q3 2019, David M. Knott held 128 positions worth $238M, up 0.41% from $237M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

David M. Knott deployed $11M of net new capital in Q3 2019, opening 17 new positions and adding to 22 existing holdings. Its largest new stake was FS KKR Capital: 381,750 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 32% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Apple, an estimated $5.02M trimmed.

  • David M. Knott's largest Q3 2019 buy was FS KKR Capital: 381,750 shares worth $8.9M.
  • David M. Knott added most to Stericycle Inc in Q3 2019, an estimated $2.09M increase.
  • David M. Knott's biggest Q3 2019 reduction was Apple, cutting an estimated $5.02M.
  • David M. Knott fully exited Lowe's Companies in Q3 2019, selling an estimated $4.54M.
  • David M. Knott's ten largest holdings make up 58% of its $238M portfolio in Q3 2019.
  • David M. Knott opened 17 new positions and closed 9 in Q3 2019.
  • David M. Knott's portfolio value rose 0.41% quarter-over-quarter to $238M.

Based on David M. Knott's 13F filing for Q3 2019, filed 12 Nov 2019.